ArticleBrain tumor pathology2026

CDKN2A/B status and histological grade independently predict post-recurrence survival in recurrent IDH-mutant astrocytoma.

Shota Yamashita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.